The rise of autologous HCT for autoimmune diseases: what is behind it and what does it mean for the future of treatment? An update on behalf of the EBMT Autoimmune Diseases Working Party

Expert Rev Clin Immunol. 2019 Oct;15(10):981-985. doi: 10.1080/1744666X.2019.1656526. Epub 2019 Sep 16.

Authors

John A Snowden¹, Manuela Badoglio², Tobias Alexander³

Affiliations

¹ Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust , Sheffield , UK.
² EBMT Data Office, Department of Haematology, Saint Antoine Hospital - INSERM UMR 938 - Université Pierre et Marie Curie , Paris , France.
³ Department of Rheumatology and Clinical Immunology, Charité - University Medicine Berlin , Berlin , Germany.

PMID: 31414932
DOI: 10.1080/1744666X.2019.1656526

No abstract available

Keywords: Autoimmune diseases; autologous; bone marrow transplantation; hematopoietic cell transplantation; stem cells.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Autoimmune Diseases / therapy*
Crohn Disease / therapy
Hematopoietic Stem Cell Transplantation / methods*
Humans
Multiple Sclerosis / therapy
Rheumatic Diseases / therapy
Transplantation, Autologous